Cargando…
Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?
New guidelines have emphasized the primacy of starting the four key life‐saving therapies for patients with heart failure and reduced ejection fraction as quickly as possible, with titration to ‘target dose’ of these, as secondary consideration. In this article, we examine the reasons for this chang...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303189/ https://www.ncbi.nlm.nih.gov/pubmed/35119172 http://dx.doi.org/10.1002/ejhf.2447 |